NCT02751385 Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer Status TERMINATED Phase PHASE1
NCT02733627 To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1467335 Following Multiple Dose Administration Over 28 Days Status COMPLETED Phase PHASE1
NCT02732951 Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema Status COMPLETED Phase PHASE2
NCT02722135 A Study to Find a Safe Dose of Volasertib Given in Addition to Standard Salvage Chemotherapy in Children (Age 3 Months to Less Than 18 Years) With Acute Myeloid Leukaemia, in Whom Front-line Chemotherapy Failed Status WITHDRAWN Phase PHASE1
NCT02721875 Trial of Volasertib With or Without Azacitidine in Patients With Myelodysplastic Syndromes Status TERMINATED Phase PHASE1
NCT02720757 Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With COPD (OTIVACTO) Status TERMINATED Phase N/A
NCT02719639 OTIVACTO Regional Center Vienna (RCV) Non-Interventional Study (NIS) Status COMPLETED Phase N/A
NCT02719184 Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease) Status COMPLETED Phase N/A
NCT02719171 BI 655066/ABBV-066/Risankizumab Compared to Placebo in Patients With Active Psoriatic Arthritis Status COMPLETED Phase PHASE2
NCT02710630 Bioavailability Study of Five Tablet Formulations of Dabigatran Etexilate Compared to Commercial Capsule Formulation in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02706925 To Assess Safety, Tolerability and Pharmacokinetics of BI 443651 in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02702011 Empa Add on to Insulin in Japanese Patient With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT02696616 Single Rising Dose Study of BI 655088 Administered Intravenously in Healthy Male Volunteers Status COMPLETED Phase PHASE1